Kwality Pharma

Market Cap: Micro Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE552U01010
NSEID:
BSEID: 539997

INR

817.95

40.95 (5.27%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 2.69 k

Click here to access the older version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Divi's Lab.

Cipla

Kwality Pharma

Sun Pharma.Inds.

Torrent Pharma

Fermenta Biotec.

NGL Fine Chem

Mankind Pharma

Bharat Parenter.

Wanbury

Sudarshan Pharma

Why is Kwality Pharmaceuticals Ltd ?

Poor long term growth as Operating profit has grown by an annual rate 4.96% of over the last 5 years

Stock is technically in a Mildly Bearish range

The technical trend has deteriorated from Mildly Bullish on 04-Apr-25 and has generated -1.16% returns since then
The stocks Bollinger Band and KST technical factors are also Bearish

Despite the size of the company, domestic mutual funds hold only 0% of the company

Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Kwality Pharma for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Kwality Pharma

73.98%

1.34

55.51%

SENSEX

0.45%

0.03

14.48%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

18.61%

EBIT Growth (5y)

4.96%

EBIT to Interest (avg)

19.12

Debt to EBITDA (avg)

0.86

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.94

Tax Ratio

28.00%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.03%

ROCE (avg)

16.61%

ROE (avg)

16.77%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.34

EV to EBIT

15.85

EV to EBITDA

11.99

EV to Capital Employed

2.68

EV to Sales

2.60

PEG Ratio

1.06

Dividend Yield

ROCE (Latest)

16.61%

ROE (Latest)

14.06%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company

OPERATING PROFIT TO INTEREST(Q)

Highest at 7.95 times

PAT(HY)

At Rs 17.00 cr has Grown at 22.04 %

EPS(Q)

Highest at Rs 8.22

0What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Loading Valuation Snapshot...

Here's what is working for Kwality Pharma

Operating Profit to Interest - Quarterly

Highest at 7.95 times and Grown

each quarter in the last five quarters

MOJO Watch

The company's ability to manage interest payments is improving

Operating Profit to Interest

Profit After Tax (PAT) - Half Yearly

At Rs 17.00 cr has Grown at 22.04 %

Year on Year (YoY)

MOJO Watch

Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly

Highest at Rs 8.22

in the last five quarters

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)